Nevertheless, little has been known to date about the reasons for the two-sided properties of FOSB in NSCLC and the molecular mechanisms involved, which might emerge as a main barrier to the application of FOSB into the management tactics and clinical decision for NSCLC. This evidence concerns the gene FOSB and non-small cell lung carcinoma.